已发表论文

通过网络药理学和非靶向脂质组学探索 S. baicalensis  对脂质代谢的潜在机制

 

Authors Ge PY, Qi YY, Qu SY, Zhao X, Ni S, Yao ZY, Guo R, Yang NY, Zhang QC, Zhu HX

Received 13 January 2021

Accepted for publication 31 March 2021

Published 4 May 2021 Volume 2021:15 Pages 1915—1930

DOI https://doi.org/10.2147/DDDT.S301679

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Georgios D. Panos


Background: S. baicalensis , a traditional herb, has great potential in treating diseases associated with aberrant lipid metabolism, such as inflammation, hyperlipidemia, atherosclerosis and Alzheimer’s disease.
Aim of the Study: To elucidate the mechanism by which S. baicalensis  modulates lipid metabolism and explore the medicinal effects of S. baicalensis  at a holistic level.
Materials and Methods: The potential active ingredients of S. baicalensis  and targets involved in regulating lipid metabolism were identified using a network pharmacology approach. Metabolomics was utilized to compare lipids that were altered after S. baicalensis  treatment in order to identify significantly altered metabolites, and crucial targets and compounds were validated by molecular docking.
Results: Steroid biosynthesis, sphingolipid metabolism, the PPAR signaling pathway and glycerolipid metabolism were enriched and predicted to be potential pathways upon which S. baicalensis  acts. Further metabolomics assays revealed 14 significantly different metabolites were identified as lipid metabolism-associated elements. After the pathway enrichment analysis of the metabolites, cholesterol metabolism and sphingolipid metabolism were identified as the most relevant pathways. Based on the results of the pathway analysis, sphingolipid and cholesterol biosynthesis and glycerophospholipid metabolism were regarded as key pathways in which S. baicalensis  is involved to regulate lipid metabolism.
Conclusion: According to our metabolomics results, S. baicalensis  may exert its therapeutic effects by regulating the cholesterol biosynthesis and sphingolipid metabolism pathways. Upon further analysis of the altered metabolites in certain pathways, agents downstream of squalene were significantly upregulated; however, the substrate of SQLE was surprisingly increased. By combining evidence from molecular docking, we speculated that baicalin, a major ingredient of S. baicalensis , may suppress cholesterol biosynthesis by inhibiting SQLE and LSS, which are important enzymes in the cholesterol biosynthesis pathway. In summary, this study provides new insights into the therapeutic effects of S. baicalensis  on lipid metabolism using network pharmacology and lipidomics.
Keywords: S. baicalensis , network pharmacology, cortex metabolomics, lipid metabolism, molecular docking